153 related articles for article (PubMed ID: 37300692)
1. Tet2-mediated DNA demethylation regulates the proliferation and apoptosis of human leukemia K562 cells.
Qiao Y; Zhou Y; Yang H; He Z; Fan A
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):23-27. PubMed ID: 37300692
[TBL] [Abstract][Full Text] [Related]
2. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
3. The TET2 interactors and their links to hematological malignancies.
Pan F; Weeks O; Yang FC; Xu M
IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
[TBL] [Abstract][Full Text] [Related]
4. Structural insight into substrate preference for TET-mediated oxidation.
Hu L; Lu J; Cheng J; Rao Q; Li Z; Hou H; Lou Z; Zhang L; Li W; Gong W; Liu M; Sun C; Yin X; Li J; Tan X; Wang P; Wang Y; Fang D; Cui Q; Yang P; He C; Jiang H; Luo C; Xu Y
Nature; 2015 Nov; 527(7576):118-22. PubMed ID: 26524525
[TBL] [Abstract][Full Text] [Related]
5. Connections between TET proteins and aberrant DNA modification in cancer.
Huang Y; Rao A
Trends Genet; 2014 Oct; 30(10):464-74. PubMed ID: 25132561
[TBL] [Abstract][Full Text] [Related]
6. PRDM14 promotes active DNA demethylation through the ten-eleven translocation (TET)-mediated base excision repair pathway in embryonic stem cells.
Okashita N; Kumaki Y; Ebi K; Nishi M; Okamoto Y; Nakayama M; Hashimoto S; Nakamura T; Sugasawa K; Kojima N; Takada T; Okano M; Seki Y
Development; 2014 Jan; 141(2):269-80. PubMed ID: 24335252
[TBL] [Abstract][Full Text] [Related]
7. Using NMR to Monitor TET-Dependent Methylcytosine Dioxygenase Activity and Regulation.
Treadway CJ; Boyer JA; Yang S; Yang H; Liu M; Li Z; Cheng M; Marzluff WF; Ye D; Xiong Y; Baldwin AS; Zhang Q; Brown NG
ACS Chem Biol; 2024 Jan; 19(1):15-21. PubMed ID: 38193366
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies.
Lio CJ; Yuita H; Rao A
Blood; 2019 Oct; 134(18):1487-1497. PubMed ID: 31467060
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms that regulate the activities of TET proteins.
Joshi K; Liu S; Breslin S J P; Zhang J
Cell Mol Life Sci; 2022 Jun; 79(7):363. PubMed ID: 35705880
[TBL] [Abstract][Full Text] [Related]
10. TET-mediated DNA demethylation plays an important role in arsenic-induced HBE cells oxidative stress via regulating promoter methylation of OGG1 and GSTP1.
Wang Q; Wang W; Zhang A
Toxicol In Vitro; 2021 Apr; 72():105075. PubMed ID: 33388378
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies.
Li W; Xu L
Oncol Res Treat; 2019; 42(6):309-318. PubMed ID: 31055566
[TBL] [Abstract][Full Text] [Related]
12. Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.
Qi Q; Wang Q; Liu K; Bian J; Yu Z; Hou J
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955629
[TBL] [Abstract][Full Text] [Related]
13. Vitamin C boosts DNA demethylation in TET2 germline mutation carriers.
Taira A; Palin K; Kuosmanen A; Välimäki N; Kuittinen O; Kuismin O; Kaasinen E; Rajamäki K; Aaltonen LA
Clin Epigenetics; 2023 Jan; 15(1):7. PubMed ID: 36639817
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
15. DNA methylcytosine dioxygenase ten-eleven translocation 2 enhances lipopolysaccharide-induced cytokine expression in human dental pulp cells by regulating MyD88 hydroxymethylation.
Wang X; Feng Z; Li Q; Yi B; Xu Q
Cell Tissue Res; 2018 Aug; 373(2):477-485. PubMed ID: 29654353
[TBL] [Abstract][Full Text] [Related]
16. TET-mediated active DNA demethylation: mechanism, function and beyond.
Wu X; Zhang Y
Nat Rev Genet; 2017 Sep; 18(9):517-534. PubMed ID: 28555658
[TBL] [Abstract][Full Text] [Related]
17. Distinct and stage-specific contributions of TET1 and TET2 to stepwise cytosine oxidation in the transition from naive to primed pluripotency.
Mulholland CB; Traube FR; Ugur E; Parsa E; Eckl EM; Schönung M; Modic M; Bartoschek MD; Stolz P; Ryan J; Carell T; Leonhardt H; Bultmann S
Sci Rep; 2020 Jul; 10(1):12066. PubMed ID: 32694513
[TBL] [Abstract][Full Text] [Related]
18. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
Nakajima H; Kunimoto H
Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
[TBL] [Abstract][Full Text] [Related]
19. TET2 in Normal and Malignant Hematopoiesis.
Bowman RL; Levine RL
Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28242787
[TBL] [Abstract][Full Text] [Related]
20. Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.
Adam S; Bräcker J; Klingel V; Osteresch B; Radde NE; Brockmeyer J; Bashtrykov P; Jeltsch A
Commun Biol; 2022 Jan; 5(1):92. PubMed ID: 35075236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
